As patient needs evolve, there’s a growing demand for targeted and personalized treatments, paving the way for groundbreaking advancements in biotechnology, particularly in gene and cell therapies. Among the key players in this dynamic landscape are monoclonal antibodies, vaccines, insulin, and gene-based therapies